Viatris
VTRS
#1651
Rank
HK$96.68 B
Marketcap
HK$83.75
Share price
-0.74%
Change (1 day)
-14.28%
Change (1 year)

P/E ratio for Viatris (VTRS)

P/E ratio as of December 2025 (TTM): -3.48

According to Viatris's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -3.4822. At the end of 2024 the company had a P/E ratio of -23.0.

P/E ratio history for Viatris from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2024-23.0-111.51%
20232003390.35%
20225.74-152.63%
2021-10.9
20195541562.77%
201833.324.76%
201726.7-22.96%
201634.735.69%
201525.536.48%
201418.7
201214.6

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Onconova Therapeutics
ONTX
-0.9953-71.42%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-5.63 61.54%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.